Resistance to bortezomib in breast cancer cells that downregulate Bim through FOXA1 O-GlcNAcylation

Yubo Liu1, Xue Wang1, Tong Zhu1

  • 1Department of Biochemistry, School of Life Science & Medicine, Dalian University of Technology, Panjin, China.

Insights

Bortezomib resistance in breast cancer is linked to elevated O-GlcNAc modification, which reduces the stability of FOXA1 and suppresses apoptosis. Combining Bortezomib with an O-GlcNAc inhibitor can overcome this resistance.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Bortezomib (BTZ) is a proteasome inhibitor used in cancer therapy, but its efficacy varies across cancer types, with limited success in breast cancer.
  • The mechanisms underlying Bortezomib resistance in breast cancer are not fully understood, hindering effective treatment strategies.

Purpose of the Study:

  • To elucidate the molecular mechanisms of Bortezomib resistance in breast cancer cells.
  • To investigate the role of O-GlcNAc modification in Bortezomib resistance.
  • To identify potential therapeutic strategies to overcome Bortezomib resistance.

Main Methods:

  • Treatment of breast cancer cell lines (MCF-7, T47D, MDA-MB-231) with Bortezomib.
  • Assessment of cellular O-GlcNAc modification levels.
  • Analysis of pioneer factor FOXA1 protein stability and its interaction with O-GlcNAc.
  • Evaluation of Bim gene expression and its role in apoptosis.
  • Combination therapy using Bortezomib and an O-GlcNAc inhibitor (L01).

Main Results:

  • Bortezomib treatment significantly increased O-GlcNAc modification in resistant breast cancer cells (MCF-7, T47D) but not in sensitive cells (MDA-MB-231).
  • Acquired Bortezomib resistance in MDA-MB-231 cells correlated with increased O-GlcNAcylation.
  • Elevated O-GlcNAc reduced FOXA1 protein stability, leading to transcriptional downregulation of the proapoptotic gene Bim.
  • This Bim deficiency suppressed Bortezomib-induced apoptosis in resistant breast cancer cells.
  • Co-treatment with Bortezomib and the O-GlcNAc inhibitor L01 sensitized resistant cells to Bortezomib.

Conclusions:

  • Elevated O-GlcNAc modification is a key mechanism contributing to Bortezomib resistance in breast cancer.
  • The O-GlcNAc/FOXA1/Bim pathway regulates apoptosis and Bortezomib sensitivity.
  • Combining Bortezomib with O-GlcNAc inhibitors represents a promising therapeutic strategy to overcome Bortezomib resistance in breast cancer.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.5K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.9K
Equivalent Resistance01:16

Equivalent Resistance

In circuit analysis, situations often arise where resistors are neither in series nor parallel configurations. To tackle such scenarios, three-terminal equivalent networks like the wye (Y) (Figure 1 (a)) or tee (T) and delta (Δ) (Figure 1 (b)) or pi (π) networks come into play. These networks offer versatile solutions and are frequently encountered in various applications, including three-phase electrical systems, electrical filters, and matching networks.
976
Resistance and Conductance01:25

Resistance and Conductance

A conductor's DC resistance at a given temperature is influenced by its resistivity, length, and cross-sectional area. Resistivity is an inherent property of the conductor material, with annealed copper serving as the international standard for measurement. For instance, the resistivity of hard-drawn aluminum at 20 degrees Celsius is 61% of the standard conductivity of annealed copper.
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
509